SEC Form 4 · accession 0001209191-15-025705
ANTARES PHARMA, INC. · ATRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James E Fickenscher
Officer — Senior Vice President & CFO
Period of report
Mar 10, 2015
Accepted (ET)
Mar 12, 2015 · 5:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001016169
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1,F2 | $2.62 | Mar 10, 2015 | A | 10,000 | A | — | Mar 9, 2025 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan.
- F2The options vest in equal quarterly installments over one year beginning on March 10, 2015.